Role of innate cytokines in mycobacterial infection

[1]  J. Keane,et al.  IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages. , 2011, American journal of respiratory cell and molecular biology.

[2]  Werner Müller,et al.  gp130 on macrophages/granulocytes modulates inflammation during experimental tuberculosis. , 2011, European journal of cell biology.

[3]  G. Kaplan,et al.  Innate Immune Response to Mycobacterium tuberculosis Beijing and Other Genotypes , 2010, PloS one.

[4]  C. Fielding,et al.  A role for IL-27p28 as an antagonist of gp130-mediated signaling , 2010, Nature Immunology.

[5]  B. Ryffel,et al.  Limited Role for Lymphotoxin α in the Host Immune Response to Mycobacterium tuberculosis , 2010, The Journal of Immunology.

[6]  S. Behar,et al.  Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? , 2010, Nature Reviews Microbiology.

[7]  J. Tschopp,et al.  NALP3 is not necessary for early protection against experimental tuberculosis. , 2010, Immunobiology.

[8]  M. Braunstein,et al.  Granuloma Formation and Host Defense in Chronic Mycobacterium tuberculosis Infection Requires PYCARD/ASC but Not NLRP3 or Caspase-1 , 2010, PloS one.

[9]  J. Pedrosa,et al.  Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis , 2010, The Journal of experimental medicine.

[10]  S. Behar,et al.  Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis , 2010, Nature Immunology.

[11]  P. Patel,et al.  Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer. , 2010, Immunotherapy.

[12]  J. Keane,et al.  How tumour necrosis factor blockers interfere with tuberculosis immunity , 2010, Clinical and experimental immunology.

[13]  Virginia Pascual,et al.  An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.

[14]  A. Sher,et al.  Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. , 2010, The Journal of clinical investigation.

[15]  S. Nakae,et al.  Essential Role of IL-17A in the Formation of a Mycobacterial Infection-Induced Granuloma in the Lung , 2010, The Journal of Immunology.

[16]  A. Sher,et al.  Cutting Edge: Caspase-1 Independent IL-1β Production Is Critical for Host Resistance to Mycobacterium tuberculosis and Does Not Require TLR Signaling In Vivo , 2010, The Journal of Immunology.

[17]  S. Khader,et al.  Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rβ1 isoform that enhances DC migration , 2010, The Journal of experimental medicine.

[18]  Kelly J. Hitchens,et al.  Cutting Edge: Mincle Is Essential for Recognition and Adjuvanticity of the Mycobacterial Cord Factor and its Synthetic Analog Trehalose-Dibehenate , 2010, The Journal of Immunology.

[19]  David M. Tobin,et al.  The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans , 2010, Cell.

[20]  S. Kaufmann,et al.  A role for IL‐18 in protective immunity against Mycobacterium tuberculosis , 2010, European journal of immunology.

[21]  A. Waisman,et al.  IL-23 Receptor Regulates Unconventional IL-17–Producing T Cells That Control Bacterial Infections , 2010, The Journal of Immunology.

[22]  J. Scheller,et al.  Loss of CD4+ T Cell IL-6R Expression during Inflammation Underlines a Role for IL-6 Trans Signaling in the Local Maintenance of Th17 Cells , 2010, The Journal of Immunology.

[23]  S. Akira,et al.  Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle , 2009, The Journal of experimental medicine.

[24]  M. Feldmann,et al.  Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis , 2009, Nature Reviews Rheumatology.

[25]  S. Niemann,et al.  Autophagy Gene Variant IRGM −261T Contributes to Protection from Tuberculosis Caused by Mycobacterium tuberculosis but Not by M. africanum Strains , 2009, PLoS pathogens.

[26]  S. Fortune,et al.  NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis , 2009, PLoS pathogens.

[27]  K. Nocka,et al.  Human alveolar macrophage gene responses to Mycobacterium tuberculosis strains H37Ra and H37Rv. , 2009, American journal of respiratory cell and molecular biology.

[28]  T. van der Poll,et al.  ST2 deficient mice display a normal host defense against pulmonary infection with Mycobacterium tuberculosis. , 2009, Microbes and infection.

[29]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[30]  I. Orme,et al.  Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. , 2009, Tuberculosis.

[31]  S. Khader,et al.  The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis , 2008, Immunological reviews.

[32]  J. Casanova,et al.  Inborn errors of interferon (IFN)‐mediated immunity in humans: insights into the respective roles of IFN‐α/β, IFN‐γ, and IFN‐λ in host defense , 2008, Immunological reviews.

[33]  Minjian Chen,et al.  Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death , 2008, The Journal of experimental medicine.

[34]  D. Flaherty,et al.  Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice1 , 2008, The Journal of Immunology.

[35]  O. Bottasso,et al.  The use of mycobacterial adjuvant-based agents for immunotherapy of cancer. , 2008, Vaccine.

[36]  E. Brown,et al.  ESX‐1‐dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection , 2008, Cellular Microbiology.

[37]  U. Schaible,et al.  Innate immunity in tuberculosis: myths and truth. , 2008, Microbes and infection.

[38]  G. Trinchieri,et al.  Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells , 2008, The Journal of experimental medicine.

[39]  Christopher A Hunter,et al.  Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10 , 2007, Nature Immunology.

[40]  M. Neuenhahn,et al.  NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ , 2007, Cell.

[41]  L. Settas,et al.  Reactivation of pulmonary tuberculosis in a patient with rheumatoid arthritis during treatment with IL-1 receptor antagonists (anakinra). , 2007, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[42]  B. Ryffel,et al.  IL-1 Receptor-Mediated Signal Is an Essential Component of MyD88-Dependent Innate Response to Mycobacterium tuberculosis Infection , 2007, The Journal of Immunology.

[43]  I. Orme,et al.  The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation1 , 2007, The Journal of Immunology.

[44]  R. Kastelein,et al.  Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. , 2007, Annual review of immunology.

[45]  S. Nakae,et al.  IL-17-Mediated Regulation of Innate and Acquired Immune Response against Pulmonary Mycobacterium bovis Bacille Calmette-Guérin Infection1 , 2007, The Journal of Immunology.

[46]  J. Johndrow,et al.  The Type I IFN Response to Infection with Mycobacterium tuberculosis Requires ESX-1-Mediated Secretion and Contributes to Pathogenesis1 , 2007, The Journal of Immunology.

[47]  J. Casanova,et al.  Inborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features , 2006 .

[48]  A. Sher,et al.  NK Cell-Derived IFN-γ Differentially Regulates Innate Resistance and Neutrophil Response in T Cell-Deficient Hosts Infected with Mycobacterium tuberculosis , 2006, The Journal of Immunology.

[49]  J. Flynn,et al.  IL-17 Production Is Dominated by γδ T Cells rather than CD4 T Cells during Mycobacterium tuberculosis Infection1 , 2006, The Journal of Immunology.

[50]  L. Hennighausen,et al.  Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system , 2006, Nature Immunology.

[51]  S. Swain,et al.  Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection , 2006, The Journal of experimental medicine.

[52]  F. Gao,et al.  Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence. , 2006, The Journal of clinical investigation.

[53]  J. Anaya,et al.  Analysis of IL1B, TAP1, TAP2 and IKBL polymorphisms on susceptibility to tuberculosis. , 2006, Tissue antigens.

[54]  Stefan Niemann,et al.  Variable host-pathogen compatibility in Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[55]  A. Sher,et al.  TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis , 2005, The Journal of experimental medicine.

[56]  G. Kaplan,et al.  Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[57]  E. N. Miller,et al.  Polymorphism in IL1B: IL1B—511 association with tuberculosis and decreased lipopolysaccharide-induced IL-1β in IFN-γ primed ex-vivo whole blood assay , 2005 .

[58]  S. Khader,et al.  IL-23 Compensates for the Absence of IL-12p70 and Is Essential for the IL-17 Response during Tuberculosis but Is Dispensable for Protection and Antigen-Specific IFN-γ Responses if IL-12p70 Is Available1 , 2005, The Journal of Immunology.

[59]  A. Sher,et al.  Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. , 2005, The Journal of clinical investigation.

[60]  W. Britton,et al.  Transmembrane TNF Is Sufficient to Initiate Cell Migration and Granuloma Formation and Provide Acute, but Not Long-Term, Control of Mycobacterium tuberculosis Infection1 , 2005, The Journal of Immunology.

[61]  A. Sher,et al.  Maintenance of Pulmonary Th1 Effector Function in Chronic Tuberculosis Requires Persistent IL-12 Production , 2005, The Journal of Immunology.

[62]  Reto Guler,et al.  Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections. , 2005, The American journal of pathology.

[63]  T. Mak,et al.  The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis 1 , 2005, The Journal of Immunology.

[64]  S. Khader,et al.  IL-27 Signaling Compromises Control of Bacterial Growth in Mycobacteria-Infected Mice1 , 2004, The Journal of Immunology.

[65]  B. Ryffel,et al.  Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. , 2004, The Journal of clinical investigation.

[66]  M. Reed,et al.  A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response , 2004, Nature.

[67]  Ryan M. O’Connell,et al.  Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection , 2004, The Journal of experimental medicine.

[68]  A. Sher,et al.  MyD88-Deficient Mice Display a Profound Loss in Resistance to Mycobacterium tuberculosis Associated with Partially Impaired Th1 Cytokine and Nitric Oxide Synthase 2 Expression , 2004, Infection and Immunity.

[69]  Matthijs Kramer,et al.  Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[70]  I. Orme,et al.  NK Cells Respond to Pulmonary Infection with Mycobacterium tuberculosis, but Play a Minimal Role in Protection 1 , 2003, The Journal of Immunology.

[71]  G. Trinchieri,et al.  The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. , 2003, Immunity.

[72]  Carmen M. Collazo-Custodio,et al.  Mice Lacking Myeloid Differentiation Factor 88 Display Profound Defects in Host Resistance and Immune Responses to Mycobacterium avium Infection Not Exhibited by Toll-Like Receptor 2 (TLR2)- and TLR4-Deficient Animals , 2003, The Journal of Immunology.

[73]  S. Akira,et al.  Mycobacterial Infection in MyD88‐Deficient Mice , 2003, Microbiology and immunology.

[74]  S. Scheu,et al.  The Lymphotoxin β Receptor Is Critically Involved in Controlling Infections with the Intracellular Pathogens Mycobacterium tuberculosis and Listeria monocytogenes1 , 2003, The Journal of Immunology.

[75]  M. Newport,et al.  Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. , 2002, The Journal of infectious diseases.

[76]  I. Orme,et al.  In Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice1 , 2002, The Journal of Immunology.

[77]  Andrew G. D. Bean,et al.  TNF Regulates Chemokine Induction Essential for Cell Recruitment, Granuloma Formation, and Clearance of Mycobacterial Infection1 , 2002, The Journal of Immunology.

[78]  I. Orme,et al.  Mice Lacking Bioactive IL-12 Can Generate Protective, Antigen-Specific Cellular Responses to Mycobacterial Infection Only if the IL-12 p40 Subunit Is Present1 , 2002, The Journal of Immunology.

[79]  F. Brombacher,et al.  A Protective and Agonistic Function of IL-12p40 in Mycobacterial Infection1 , 2001, The Journal of Immunology.

[80]  S. Mizuno,et al.  Role of Interleukin (IL)‐1 Type 1 Receptor in Mycobacterial Infection , 2001, Microbiology and immunology.

[81]  G. Kaplan,et al.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[82]  N. Kajiwara,et al.  Interleukin 12 P40 Production by Barrier Epithelial Cells during Airway Inflammation , 2001, The Journal of experimental medicine.

[83]  Warwick J. Britton,et al.  Secreted Lymphotoxin-α Is Essential for the Control of an Intracellular Bacterial Infection , 2001, The Journal of experimental medicine.

[84]  T. van der Poll,et al.  Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. , 2000, The Journal of infectious diseases.

[85]  I. Orme,et al.  Interleukin-6 Induces Early Gamma Interferon Production in the Infected Lung but Is Not Required for Generation of Specific Immunity to Mycobacterium tuberculosisInfection , 2000, Infection and Immunity.

[86]  Y. Iwakura,et al.  Protective Role of Interleukin-1 in Mycobacterial Infection in IL-1 α/β Double-Knockout Mice , 2000, Laboratory Investigation.

[87]  M. Glickman,et al.  A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. , 2000, Molecular cell.

[88]  R. Appelberg,et al.  Interleukin-6 and Interleukin-12 Participate in Induction of a Type 1 Protective T-Cell Response during Vaccination with a Tuberculosis Subunit Vaccine , 1999, Infection and Immunity.

[89]  R. Wilkinson,et al.  Influence of Polymorphism in the Genes for the Interleukin (IL)-1 Receptor Antagonist and IL-1β on Tuberculosis , 1999, The Journal of experimental medicine.

[90]  S. Akira,et al.  Role of Interleukin-18 (IL-18) in Mycobacterial Infection in IL-18-Gene-Disrupted Mice , 1999, Infection and Immunity.

[91]  F. Deist,et al.  Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. , 1998, Science.

[92]  S. Kaufmann,et al.  Lethal tuberculosis in interleukin-6-deficient mutant mice , 1997, Infection and immunity.

[93]  C. Lowenstein,et al.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.

[94]  R. Appelberg,et al.  Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice. , 1994, Immunology.

[95]  J. Abrams,et al.  Cytokine production at the site of disease in human tuberculosis , 1993, Infection and immunity.

[96]  M. Denis.  Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection , 1991, Infection and immunity.

[97]  J. Freund,et al.  Antibody formation and sensitization with the aid of adjuvants. , 1948, Journal of immunology.

[98]  R. Koch,et al.  Fortsetzung der Mittheilungen über ein Heilmittel gegen Tuberculose , 1891 .

[99]  S. Akira,et al.  References Subscriptions Permissions Email Alerts Contribution of IL-18 to Th1 Response and Host Defense Against Infection by Mycobacterium tuberculosis: A Comparative Study with IL-12p40 , 2013 .

[100]  H. Whittle,et al.  Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[101]  Harald Dietrich,et al.  Brief Definitive Report Adjuvanticity of a Synthetic Cord Factor Analogue for Subunit Mycobacterium Tuberculosis Vaccination Requires Fcr ␥ – Syk – Card9 – Dependent Innate Immune Activation , 2022 .

[102]  Lymphotoxin- (cid:1) and TNF Have Essential but Independent Roles in the Evolution of the Granulomatous Response in Experimental Leprosy , 2022 .